{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:59:59Z","timestamp":1791932399776,"version":"4.3.4"},"reference-count":69,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,2]],"date-time":"2023-04-02T00:00:00Z","timestamp":1680393600000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008510","name":"University of Maryland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["U19-AI135995"],"award-info":[{"award-number":["U19-AI135995"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["U19-AI142790"],"award-info":[{"award-number":["U19-AI142790"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency","doi-asserted-by":"publisher","award":["HDTRA1-15-C-0058"],"award-info":[{"award-number":["HDTRA1-15-C-0058"]}],"id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.celrep.2023.112402","type":"journal-article","created":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T06:30:21Z","timestamp":1681540221000},"page":"112402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates"],"prefix":"10.1016","volume":"42","author":[{"given":"Bronwyn M.","family":"Gunn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan P.","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianna","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabian","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anush","family":"Devadhasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jishnu","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avlant","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Shurtleff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheri","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Eichberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd J.","family":"Suscovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica Ollmann","family":"Saphire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Lauffenburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth-Ann","family":"Coller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub K.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galit","family":"Alter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2023.112402_bib1","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1126\/science.aab3920","article-title":"EBOLA VACCINE. VSV-EBOV rapidly protects macaques against infection with the 2014\/15 Ebola virus outbreak strain","volume":"349","author":"Marzi","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.celrep.2023.112402_bib2","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1414216","article-title":"A recombinant vesicular stomatitis virus Ebola vaccine","volume":"376","author":"Regules","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2023.112402_bib3","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa1502924","article-title":"Phase 1 trials of rVSV Ebola vaccine in Africa and Europe","volume":"374","author":"Agnandji","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2023.112402_bib4","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S1473-3099(17)30313-4","article-title":"Safety and immunogenicity of the rVSVG-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study","volume":"17","author":"Heppner","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.celrep.2023.112402_bib5","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/infdis\/jiz241","article-title":"Immunogenicity, lot consistency, and extended safety of rVSVDeltaG-ZEBOV-GP vaccine: a phase 3 randomized, double-blind, placebo-controlled study in healthy adults","volume":"220","author":"Halperin","year":"2019","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.celrep.2023.112402_bib6","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1056\/NEJMoa1614067","article-title":"Phase 2 placebo-controlled trial of two vaccines to prevent Ebola in Liberia","volume":"377","author":"Kennedy","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2023.112402_bib7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!)","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.celrep.2023.112402_bib8","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1016\/S2666-5247(20)30198-1","article-title":"Estimation of the correlates of protection of the rVSV\u0394G-ZEBOV-GP Zaire ebolavirus vaccine: a post-hoc analysis of data from phase 2\/3 clinical trials","volume":"2","author":"Grais","year":"2021","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.celrep.2023.112402_bib9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.smim.2018.07.003","article-title":"Correlates of vaccine-induced protective immunity against Ebola virus disease","volume":"39","author":"Medaglini","year":"2018","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.celrep.2023.112402_bib10","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1073\/pnas.1209591110","article-title":"Antibodies are necessary for rVSV\/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates","volume":"110","author":"Marzi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2023.112402_bib11","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm1258","article-title":"Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses","volume":"11","author":"Jones","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2023.112402_bib12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ebiom.2019.09.055","article-title":"Single low-dose VSV-EBOV vaccination protects cynomolgus macaques from lethal Ebola challenge","volume":"49","author":"Marzi","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.celrep.2023.112402_bib13","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.cell.2018.07.033","article-title":"Systematic analysis of monoclonal antibodies against Ebola virus GP defines features that contribute to protection","volume":"174","author":"Saphire","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2023.112402_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.chom.2018.12.004","article-title":"Development of a human antibody cocktail that deploys multiple functions to confer pan-ebolavirus protection","volume":"25","author":"Wec","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2023.112402_bib15","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.aad6117","article-title":"Structural and molecular basis for Ebola virus neutralization by protective human antibodies","volume":"351","author":"Misasi","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.celrep.2023.112402_bib16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.chom.2018.07.009","article-title":"A role for Fc function in therapeutic monoclonal antibody-mediated protection against Ebola virus","volume":"24","author":"Gunn","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2023.112402_bib17","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/s41590-018-0233-9","article-title":"Antibody-mediated protection against Ebola virus","volume":"19","author":"Saphire","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2023.112402_bib18","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/infdis\/jiz364","article-title":"Survivors of Ebola virus disease develop polyfunctional antibody responses","volume":"221","author":"Gunn","year":"2019","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.celrep.2023.112402_bib19","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.immuni.2021.03.009","article-title":"A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus","volume":"54","author":"Gunn","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2023.112402_bib20","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2217\/fvl.09.56","article-title":"Ebolavirus glycoprotein structure and mechanism of entry","volume":"4","author":"Lee","year":"2009","journal-title":"Future Virol."},{"key":"10.1016\/j.celrep.2023.112402_bib21","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1073\/pnas.93.8.3602","article-title":"The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing","volume":"93","author":"Sanchez","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2023.112402_bib22","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.1128\/JVI.72.8.6442-6447.1998","article-title":"Biochemical analysis of the secreted and virion glycoproteins of Ebola virus","volume":"72","author":"Sanchez","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2023.112402_bib23","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.1128\/JVI.02190-10","article-title":"A new Ebola virus nonstructural glycoprotein expressed through RNA editing","volume":"85","author":"Mehedi","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2023.112402_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/vim.2014.0068","article-title":"The multiple roles of sGP in Ebola pathogenesis","volume":"28","author":"de La Vega","year":"2015","journal-title":"Viral Immunol."},{"key":"10.1016\/j.celrep.2023.112402_bib25","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1126\/science.287.5458.1664","article-title":"Epitopes involved in antibody-mediated protection from Ebola virus","volume":"287","author":"Wilson","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.celrep.2023.112402_bib26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature13777","article-title":"Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp","volume":"514","author":"Qiu","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2023.112402_bib27","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1016\/j.vaccine.2020.02.044","article-title":"Prior vaccination with recombinant Vesicular Stomatitis Virus - Zaire Ebolavirus vaccine is associated with improved survival among patients with Ebolavirus infection","volume":"38","author":"Kasereka","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.celrep.2023.112402_bib28","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJMsr1904253","article-title":"The ongoing Ebola epidemic in the Democratic Republic of Congo, 2018-2019","volume":"381","author":"Ilunga Kalenga","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2023.112402_bib29","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.cell.2015.10.027","article-title":"Dissecting polyclonal vaccine-induced humoral immunity against HIV using systems Serology","volume":"163","author":"Chung","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2023.112402_bib30","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.molmed.2016.09.002","article-title":"Modulating antibody functionality in infectious disease and vaccination","volume":"22","author":"Gunn","year":"2016","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.celrep.2023.112402_bib31","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.4049\/jimmunol.1502252","article-title":"IgG binding characteristics of rhesus macaque Fc\u03b3R","volume":"197","author":"Chan","year":"2016","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2023.112402_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jim.2017.01.010","article-title":"Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles","volume":"443","author":"Brown","year":"2017","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.celrep.2023.112402_bib33","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/19420862.2016.1274845","article-title":"IgG Fc variant cross-reactivity between human and rhesus macaque Fc\u03b3Rs","volume":"9","author":"Boesch","year":"2017","journal-title":"mAbs"},{"key":"10.1016\/j.celrep.2023.112402_bib34","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/nm.4201","article-title":"Human antibody repertoire after VSV-Ebola vaccination identifies novel targets and virus-neutralizing IgM antibodies","volume":"22","author":"Khurana","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2023.112402_bib35","doi-asserted-by":"crossref","first-page":"e1004509","DOI":"10.1371\/journal.ppat.1004509","article-title":"Shed GP of Ebola virus triggers immune activation and increased vascular permeability","volume":"10","author":"Escudero-Perez","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2023.112402_bib36","doi-asserted-by":"crossref","first-page":"e1003065","DOI":"10.1371\/journal.ppat.1003065","article-title":"Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus","volume":"8","author":"Mohan","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2023.112402_bib37","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1084\/jem.20161512","article-title":"TLR7\/8 activation in neutrophils impairs immune complex phagocytosis through shedding of FcgRIIA","volume":"214","author":"Lood","year":"2017","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2023.112402_bib38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.immuni.2005.11.010","article-title":"Fcgamma receptors: old friends and new family members","volume":"24","author":"Nimmerjahn","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2023.112402_bib39","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature10134","article-title":"Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway","volume":"475","author":"Anthony","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2023.112402_bib40","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1172\/JCI24772","article-title":"Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions","volume":"115","author":"Boruchov","year":"2005","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2023.112402_bib41","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.chom.2017.10.011","article-title":"Multi-platform 'Omics analysis of human Ebola virus disease pathogenesis","volume":"22","author":"Eisfeld","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2023.112402_bib42","doi-asserted-by":"crossref","first-page":"5640","DOI":"10.1182\/blood-2012-01-380121","article-title":"Properties of mouse and human IgG receptors and their contribution to disease models","volume":"119","author":"Bruhns","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2023.112402_bib43","doi-asserted-by":"crossref","first-page":"e0252874","DOI":"10.1371\/journal.pone.0252874","article-title":"Natural history of disease in cynomolgus monkeys exposed to Ebola virus Kikwit strain demonstrates the reliability of this non-human primate model for Ebola virus disease","volume":"16","author":"Niemuth","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2023.112402_bib44","doi-asserted-by":"crossref","first-page":"8810","DOI":"10.1038\/s41598-021-87872-x","article-title":"Differences in host immune populations between rhesus macaques and cynomolgus macaque subspecies in relation to susceptibility to Mycobacterium tuberculosis infection","volume":"11","author":"Sibley","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2023.112402_bib45","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1038\/s41598-019-39819-6","article-title":"Differences in monocyte: lymphocyte ratio and Tuberculosis disease progression in genetically distinct populations of macaques","volume":"9","author":"Sibley","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2023.112402_bib46","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/jmp.12174","article-title":"Heterospecific SNP diversity in humans and rhesus macaque (Macaca mulatta)","volume":"44","author":"Ng","year":"2015","journal-title":"J.\u00a0Med. Primatol."},{"key":"10.1016\/j.celrep.2023.112402_bib47","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ygeno.2012.09.001","article-title":"Identifying human-rhesus macaque gene orthologs using heterospecific SNP probes","volume":"101","author":"Kanthaswamy","year":"2013","journal-title":"Genomics"},{"key":"10.1016\/j.celrep.2023.112402_bib48","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/jmp.12043","article-title":"The genetic composition of populations of cynomolgus macaques (Macaca fascicularis) used in biomedical research","volume":"42","author":"Kanthaswamy","year":"2013","journal-title":"J.\u00a0Med. Primatol."},{"key":"10.1016\/j.celrep.2023.112402_bib49","doi-asserted-by":"crossref","first-page":"110368","DOI":"10.1016\/j.celrep.2022.110368","article-title":"A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection","volume":"38","author":"Beaudoin-Bussi\u00e8res","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2023.112402_bib50","doi-asserted-by":"crossref","first-page":"100126","DOI":"10.1016\/j.xcrm.2020.100126","article-title":"Cross-sectional evaluation of humoral responses against SARS-CoV-2 spike","volume":"1","author":"Pr\u00e9vost","year":"2020","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.celrep.2023.112402_bib51","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3201\/eid2804.212037","article-title":"Durability of antibody response and frequency of SARS-CoV-2 infection 6 Months after COVID-19 vaccination in healthcare workers","volume":"28","author":"Laing","year":"2022","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.celrep.2023.112402_bib52","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1126\/science.abj4176","article-title":"Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants","volume":"373","author":"Pegu","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.celrep.2023.112402_bib53","doi-asserted-by":"crossref","first-page":"e20200004","DOI":"10.1084\/jem.20200004","article-title":"Reduced Ebola vaccine responses in CMV+ young adults is associated with expansion of CD57+KLRG1+ T\u00a0cells","volume":"217","author":"Bowyer","year":"2020","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2023.112402_bib54","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1056\/NEJMoa1410863","article-title":"Chimpanzee adenovirus vector Ebola vaccine","volume":"376","author":"Ledgerwood","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2023.112402_bib55","doi-asserted-by":"crossref","first-page":"eabg6128","DOI":"10.1126\/scitranslmed.abg6128","article-title":"Ebola vaccine-induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effects","volume":"13","author":"Meyer","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2023.112402_bib56","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tim.2018.08.008","article-title":"Can Ebola virus vaccines have universal immune correlates of protection?","volume":"27","author":"Meyer","year":"2019","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.celrep.2023.112402_bib57","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1038\/emi.2017.31","article-title":"T-cell-dependent mechanisms promote Ebola VLP-induced antibody responses, but are dispensable for vaccine-mediated protection","volume":"6","author":"Cooper","year":"2017","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.celrep.2023.112402_bib58","doi-asserted-by":"crossref","first-page":"e00597-19","DOI":"10.1128\/mBio.00597-19","article-title":"Antiviral innate responses induced by VSV-EBOV vaccination contribute to rapid protection","volume":"10","author":"Menicucci","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.celrep.2023.112402_bib69","doi-asserted-by":"crossref","first-page":"e0150919","DOI":"10.1371\/journal.pone.0150919","article-title":"Informing the Historical Record of Experimental Nonhuman Primate Infections with Ebola Virus: Genomic Characterization of USAMRIID Ebola Virus\/H.sapiens-tc\/COD\/1995\/Kikwit-9510621 Challenge Stock \u201cR4368\u201d and Its Replacement \"R4415","volume":"11","author":"Kugelman","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2023.112402_bib59","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1086\/515386","article-title":"A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever","volume":"178","author":"Bray","year":"1998","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.celrep.2023.112402_bib60","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/jcpa.2001.0502","article-title":"Pathogenesis of experimental Ebola Zaire virus infection in BALB\/c mice","volume":"125","author":"Gibb","year":"2001","journal-title":"J.\u00a0Comp. Pathol."},{"key":"10.1016\/j.celrep.2023.112402_bib61","doi-asserted-by":"crossref","first-page":"e0241016","DOI":"10.1371\/journal.pone.0241016","article-title":"Method feasibility for cross-species testing, qualification, and validation of the Filovirus Animal Nonclinical Group anti-Ebola virus glycoprotein immunoglobulin G enzyme-linked immunosorbent assay for non-human primate serum samples","volume":"15","author":"Niemuth","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2023.112402_bib62","doi-asserted-by":"crossref","first-page":"e0215457","DOI":"10.1371\/journal.pone.0215457","article-title":"Development, qualification, and validation of the Filovirus Animal Nonclinical Group anti-Ebola virus glycoprotein immunoglobulin G enzyme-linked immunosorbent assay for human serum samples","volume":"14","author":"Rudge","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2023.112402_bib63","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41586-020-03041-6","article-title":"Correlates of protection against SARS-CoV-2 in rhesus macaques","volume":"590","author":"McMahan","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2023.112402_bib64","doi-asserted-by":"crossref","first-page":"100405","DOI":"10.1016\/j.xcrm.2021.100405","article-title":"Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination","volume":"2","author":"Gorman","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.celrep.2023.112402_bib65","doi-asserted-by":"crossref","first-page":"e0214121","DOI":"10.1128\/mbio.02141-21","article-title":"Serological markers of SARS-CoV-2 reinfection","volume":"13","author":"Siddiqui","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.celrep.2023.112402_bib66","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/s41590-021-01066-1","article-title":"Robust IgM responses following intravenous vaccination with Bacille Calmette-Gu\u00e9rin associate with prevention of Mycobacterium tuberculosis infection in macaques","volume":"22","author":"Irvine","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2023.112402_bib67","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cell.2020.08.033","article-title":"Passive transfer of vaccine-elicited antibodies protects against SIV in rhesus macaques","volume":"83","author":"Alter","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2023.112402_bib68","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00251-011-0514-z","article-title":"Characterization and allelic polymorphisms of rhesus macaque (Macaca mulatta) IgG Fc receptor genes","volume":"63","author":"Nguyen","year":"2011","journal-title":"Immunogenetics"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124723004138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124723004138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T11:53:38Z","timestamp":1762602818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124723004138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S2211124723004138"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2023.112402","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2023.112402","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"112402"}}